---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-153559"
form_type: "8-K"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2021-12-27T23:59:59+00:00"
generated_at: "2026-06-27T22:23:11.503520+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Humacyte CSO Jeffrey Lawson to depart effective Dec 31, 2022; no disagreement cited

## Summary
- Dr. Jeffrey H. Lawson, Chief Surgical Officer, leaves Humacyte effective Dec 31, 2022, and resigns from board.
- Departure is mutual, not due to any disagreement with company operations, policies, or practices.
- Severance benefits per existing employment agreement; vested stock option exercise period extended to Nov 26, 2022.
- Separation agreement includes customary release of claims and supersedes other severance arrangements.

## SEC filing metadata
- accession: 0001104659-21-153559
- form_type: 8-K
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2021-12-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000110465921153559/0001104659-21-153559-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000110465921153559/tm2136325d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-153559
- JSON: https://secwatch.observer/filing/0001104659-21-153559.json
- Plain text: https://secwatch.observer/filing/0001104659-21-153559.txt

## Key facts
- Executive change
  Jeffrey H. Lawson resigned as Director at Humacyte, Inc..
  - Action: resigned
  - Role: Director
  source text: Dr. Lawson also resigned from the Company’s board of directors, effective as of the Separation Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818382/000110465921153559/0001104659-21-153559-index.htm
- Executive change
  Jeffrey H. Lawson resigned as Chief Surgical Officer at Humacyte, Inc..
  - Action: resigned
  - Role: Chief Surgical Officer
  source text: On December 23, 2021, Humacyte, Inc. (the “Company”) and Jeffrey H. Lawson, M.D., Ph.D., the Company’s Chief Surgical Officer, mutually agreed to end Dr. Lawson’s employment with the Company, effective December 31, 2022 (the “Separation Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818382/000110465921153559/0001104659-21-153559-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.